Third quarter: Outlook for 2017 confirmed

On November 9, 2017, we published our third-quarter results. On this web page you will find all information.

09 Nov 2017

From 07:00 to 15:00

We confirm our outlook for 2017 despite a challenging third quarter

  • Group sales in the third quarter at year-earlier level (+0.1%)
  • Robust organic sales growth across all regions amid negative exchange rate effects
  • Healthcare investments and business performance of Liquid Crystals impact EBITDA pre exceptionals (-8.3%)
  • Integration of Sigma-Aldrich on track
  • Net financial debt lowered by € 1.0 billion to € 10.5 billion
  • We confirm the outlook for sales and EBITDA pre for 2017

Reduction of net financial debt

“We generated healthy organic growth in Healthcare and Life Science. In Performance Materials, our diversified portfolio comprising four strong pillars is helping us cope with the challenges in Liquid Crystals. We confirm the full-year guidance despite currency headwinds. Since the beginning of the year, we have reduced our net financial debt by € 1 billion.”

(Stefan Oschmann, CEO and Chairman of the Executive Board)

Related News

View All News

Press Releases

Merck KGaA, Darmstadt, Germany, Confirms Outlook for 2017 Despite a Challenging ...

Merck KGaA, Darmstadt, Germany today reported third-quarter Group sales at the year-earlier level.


Markus Talanow

Financial Communications

Constantin Fest

Head of Investor Relations


You have accessed, but for users from your part of the world, we originally designed the following web presence

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement